Intellia Genomics Director, Jessica Seitzer, will present new data on the #CRISPR/Cas9-mediated gene knockout of KLKB1 to treat #hereditaryangioedema at @AAAAI_org’s annual meeting virtually tomorrow from 5:10-6:25 p.m. CST. Be sure to tune in! https://t.co/o0Szu7iiWu